Company intelligence / Profile preview

PKU V-Ming Investment Holdings Co., Ltd.

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

PKU V-Ming is primarily an investment holding company focused on capital management and private equity, not a biotech, pharma, or healthcare company. It has participated in high-profile investment consortiums in the life sciences sector, but there is no evidence it develops or owns specific therapies or platforms in biotech, pharma, or healthcare.

Industry: Investors

Partnerships

Beijing Sinobioway Group Co., Ltd.Sichuan Tuopai Shede Group Co., Ltd.CICC Qianhai Development (Shenzhen) Fund Management Co., Ltd.Heng Feng Investments (International) LimitedFuerde Global Investment Limited

Beyond the preview

Go deeper on PKU V-Ming Investment Holdings Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PKU V-Ming Investment Holdings Co., Ltd..

Explore the full profile